Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndrome
About
Article information:
Expert Opin Biol Ther. 2025 Apr 10.
Interventions:
Rovunaptabin (BC007)
Immunoadsorption
Plasmapheresis
Rituximab (L01FA01)
Apparative Therapy
Immunoglobulins (J06B)
Daratumumab (L01FC01)
Efgartigimod (L04AA58)
Immunoadsorption
Plasmapheresis
Rituximab (L01FA01)
Apparative Therapy
Immunoglobulins (J06B)
Daratumumab (L01FC01)
Efgartigimod (L04AA58)
Link
DOI
Abstract
#VALUE!
Authors (all)
Felix Wohlrab, Mailam Eltity, Friederike Ufer, Friedemann Paul, Carmen Scheibenbogen, Judith Bellmann-Strobl
Linked author profiles see list below.
Research projects
0
Research areas
3
Research types
1
Research networks
0
People
3
Research projects
This publication has no research projects linked or they are not public yet.
Contact
ME/CFS Research Foundation
Ballindamm 27, 20095 Hamburg, Germany
Copyright © 2022 ME/CFS Research Foundation
Imprint -
Data privacy statement